Join Index

Explore

Streams

Products

About Index

Index

By TNW

Cowen Group

0

Cowen Group

Terms of Service Privacy Policy Cookie Statement API Integrations Plans & Pricing

Built with ❤︎ by Datalicious ©2018
A daughter company of TNW.
Index.co is not affiliated with Index Ventures.

Overview

News

Investments 6

Portfolio

Portfolio Tracker

Add info

Livongo Health expands under new offering with Abbott Labs

Health Cloud

$150,000,000 Venture capital (Series C)

Orchard Therapeutics Raises $150M in Series C Financing

Funding Health

$75,000,000 IPO

VC-backed Kezar Life Sciences unveils IPO

Stock markets Health

Acquisition

Livongo Health Grows with Purchase of Weight Loss Startup Retrofit

Health

$105,000,000 Venture capital (Series E)

, ,

Livongo rakes in $105M, introduces partnership with Cambia Health Solutions

,

Cambia Health and Livongo partner to bring personal, tech-driven diabetes program to Pacific Northwest

Health Funding

$110,000,000 Venture capital (Series B)

| Gene therapy developer Orchard Therapeutics raises $110 million: Reuters

Health Funding

MyoKardia Heart Drug Boosts Blood Flow, Sends Shares Soaring

Health

Private equity

CEFC China to buy 20 percent stake in U.S. brokerage Cowen

Venture capital

Semma Therapeutics Raises Additional Funding

$52,500,000 Venture capital (Series D)

, ,

Smart diabetes management service Livongo Health raises $52.5M and looks to new markets

Health People

Livongo Health rakes in $52.5 mln

Messaging Funding Data leaks

$20,000,000 Grant

Orchard gets $20M to trial ‘bubble boy’ gene therapy

$5,000,000 Grant

,

Semma Therapeutics Receives $5M Grant from California Institute of Regenerative Medicine

£21,000,000 Venture capital (Series A)

Orchard Therapeutics Launches and Announces Academic Partnerships for Development of Transformative Gene Therapies

$44,500,000 Venture capital (Series C)

Livongo Health Completes $44.5M Series C Financing

Health Funding

Despite Sanofi’s Help, MyoKardia Prices IPO Below Expectations

Health Stock markets

Amid Biotech Swoon, Third Rock’s MyoKardia Tees up IPO

Health Funding

$20,000,000 Venture capital (Series B)

Kleiner Perkins Leads $20M Round in Livongo for Cloud-Enabled Glucose Meter

Health Funding